The natural history of breast cancer

Archives of Internal Medicine

Volumn 168, Issue 21, 2008, Pages 2302-2303

  Kaplan, Robert M ^a   Porzsolt, Franz ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; DISEASE COURSE; EDITORIAL; MAMMOGRAPHY; PRIORITY JOURNAL;

EID: 56749106996     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.168.21.2302     Document Type: Editorial

References (20)

1. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358(9290):1340-1342.
2. Zahl P-H, Mæhlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med. 2008;168(21):2311-2316.
3. Bodey B. Spontaneous regression of neoplasms: new possibilities for immunotherapy. Expert Opin Biol Ther. 2002;2(5):459-476.
4. Challis GB, Stam HJ. The spontaneous regression of cancer: a review of cases from 1900 to 1987. Acta Oncol. 1990;29(5):545-550.
5. Lewison EF. Spontaneous regression of breast cancer. Natl Cancer Inst Monogr. 1976;44:23-26.
6. Bhatnagar V, Stewart ST, Huynh V, Jorgensen G, Kaplan RM. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment. Prostate Cancer Prostatic Dis. 2006;9(2):136-146.
7. Bhatnagar V, Stewart ST, Bonney WW, Kaplan RM. Treatment options for localized prostate cancer: quality-adjusted life years and the effects of lead-time. Urology. 2004;63(1):103-109.
8. Setiawan VW, Cheng I, Stram DO, et al. A systematic assessment of common genetic variation in cyp11a and risk of breast cancer. Cancer Res. 2006;66(24):12019-12025.
9. Dave SS. Gene expression signatures and outcome prediction in mature B-cell malignancies. Curr Treat Options Oncol. 2006;7(4):261-269.
10. Brauers A, Jakse G. Epidemiology and biology of human urinary bladder cancer. J Cancer Res Clin Oncol. 2000;126(10):575-583.
11. Woods LM, Rachet B, Cooper N, Coleman MP. Predicted trends in long-term breast cancer survival in England and Wales. Br J Cancer. 2007;96(7):1135-1138.
12. Beam CA, Layde PM, Sullivan DC. Variability in the interpretation of screening mammograms by US radiologists: findings from a national sample. Arch Intern Med. 1996;156(2):209-213.
13. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study, 1: breast cancer detection and death rates among women aged 40 to 49 years. CMAJ. 1992;147(10):1459-1476.
14. Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL. Chapter 7: the Wisconsin Breast Cancer Epidemiology Simulation Model. J Natl Cancer Inst Monogr. 2006;(36):37-47.
15. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med. 1997;127(11):1023-1028.
16. Black WC, Welch HG. Screening for disease. AJR Am J Roentgenol. 1997;168(1):3-11.
17. Verkooijen HM, Fioretta GM, Rapiti E, et al. Patients' refusal of surgery strongly impairs breast cancer survival. Ann Surg. 2005;242(2):276-280.
18. Larsen SU, Rose C. Spontaneous remission of breast cancer: a literature review. Ugeskr Laeger. 1999;161(26):4001-4004.
19. Young JM, Solomon MJ, Harrison JD, Salkeld G, Butow P. Measuring patient preference and surgeon choice. Surgery. 2008;143(5):582-588.
20. Porzsolt F, Kliemt H. Ethische und empirische Grenzen randomisierter kontrollierter Studien. Med Klin. In press.